Featured News
- THT 2025 Late-Breaking Clinical Science Unveiled
- New York Valves: The Structural Heart Summit is Back!
- Jeffrey Popma, MD, Joins CRF as Chief Scientific and Strategic Officer
- Symbiosis Wins TCT 2024 Shark Tank Innovation Competition
- First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of Peripheral Artery Disease: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
- Innovate
- Investigate
- Educate
